Gargiulo Piera, Arenare Laura, Pisano Carmela, Cecere Sabrina Chiara, Falivene Sara, Greggi Stefano, Tambaro Rosa, Facchini Gaetano, De Palma Giampaolo, Scaffa Cono, Della Pepa Chiara, Pignata Sandro, Di Napoli Marilena
Department of Urology and Gynecology, Istituto Nazionale Tumori x2018;Fondazione G. Pascale', IRCCS, Naples, Italy.
Oncology. 2016;90(1):29-35. doi: 10.1159/000441226. Epub 2015 Oct 17.
The aim of this study was to analyze the long-term toxicity and quality of life (QOL) in patients with locally advanced cervical cancer (LACC) treated with chemoradiation [chemotherapy/radiotherapy (CT/RT)] or neoadjuvant CT (NACT) followed by radical surgery (RS).
Fifty-nine patients with LACC in remission after treatment with NACT + RS (n = 34) or CT/RT (n = 25) were interviewed with an Incontinence Impact Questionnaire (IIQ-7), a Quality of Life Questionnaire (EORTC QLQ-C30), and a Quality of Life Questionnaire for Cervical Cancer (EORTC QLQ-CX24) to compare long-term toxicity and QOL.
The mean age was 53 ± 9.8 and 59 ± 11.5 years in the NACT + RS and CT/RT groups, respectively. Overall, diarrhea and constipation were reported in 15 and 68%, respectively, while bladder complaints and a low level of sexual enjoyment were reported in 36 and 47%, respectively. The NACT + RS patients showed a worse sexual activity (74.71 ± 33.57 vs. 92.06 ± 17.96; p = 0.019) and sexual enjoyment (71.21 ± 23.67 vs. 88.88 ± 21.71; p = 0.040) and more frequently complained of constipation (49.01 ± 34.06 vs. 26.66 ± 31.66; p = 0.013), while CT/RT patients more frequently suffered from diarrhea (1.96 ± 7.96 vs. 14.66 ± 28.40; p = 0.017).
Many patients treated for LACC have long-term complaints regarding sexual activity and bladder and bowel function. The majority of QOL aspects were similar in the two groups at long-term follow-up. However, diarrhea was more frequent and severe in CT/RT patients, while constipation was more frequent and severe in NACT + RS patients, and they showed a worse sexual life perception. Larger randomized trials addressing these issues are needed.
本研究旨在分析接受放化疗[化疗/放疗(CT/RT)]或新辅助化疗(NACT)后行根治性手术(RS)治疗的局部晚期宫颈癌(LACC)患者的长期毒性和生活质量(QOL)。
采用尿失禁影响问卷(IIQ - 7)、生活质量问卷(EORTC QLQ - C30)和宫颈癌生活质量问卷(EORTC QLQ - CX24)对59例接受NACT + RS(n = 34)或CT/RT(n = 25)治疗后缓解的LACC患者进行访谈,以比较长期毒性和生活质量。
NACT + RS组和CT/RT组的平均年龄分别为53±9.8岁和59±11.5岁。总体而言,分别有15%和68%的患者报告有腹泻和便秘,而分别有36%和47%的患者报告有膀胱问题和性快感低下。NACT + RS组患者的性活动(74.71±33.57对92.06±17.96;p = 0.019)和性快感(71.21±23.67对88.88±21.71;p = 0.040)较差,且便秘主诉更频繁(49.01±34.06对26.66±31.66;p = 0.013),而CT/RT组患者腹泻更频繁(1.96±7.96对14.66±28.40;p = 0.017)。
许多接受LACC治疗的患者对性活动以及膀胱和肠道功能有长期抱怨。在长期随访中,两组在大多数生活质量方面相似。然而,CT/RT组患者腹泻更频繁、更严重,而NACT + RS组患者便秘更频繁、更严重,且他们对性生活的感受更差。需要开展更大规模的随机试验来解决这些问题。